Infectious Diseases Physician @GC_Health. Panathinaikos supporter and football lover. Tweets are my own.
Brisbane, Queensland
Joined June 2011
- Tweets80
- Following426
- Followers217
- Likes11.1K
Peter Simos retweeted
“Due to increasing fluoroquinolone resistance, trimethoprim-sulfamethoxazole will be recommended as the preferred oral empiric therapy for non-severe Salmonella disease.”
@SazaliBasri @HanzHc
This is interesting
TMP-SMX
contagionlive.com/view/risin…
Peter Simos retweeted
People with baseline high plama HIV-1 RNA and low CD4 counts have an increased risk of RV, LLV and virol failure with every ART, also when starting INSTI and specifically DTG. These are lifelong determinants of non virol suppression #RESPOND.
academic.oup.com/cid/advance…
Peter Simos retweeted
🆕️🔥🔥ICYMI 🔴 @CIDJournal
@VanceFowler5
The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria
Follow me+Like it +Retweet it +DM me & I'll send you a link for full text✔️ #IDTwitter #IEwikiguidelines
academic.oup.com/cid/advance…
Peter Simos retweeted
More isolates with ⬆️ voriconzaole MIC values in 2020-21. No difference in azole resistance between North QLD vs Southeast QLD acquisition 🇦🇺@burcucella @peter_simos
Aspergillus species causing invasive fungal disease in Queensland, Australia @SpringerMicBio #Mycopathologia #OpenAccess
link.springer.com/article/10…
Peter Simos retweeted
⛔️US FDA⛔️
Atovaquone oral suspension USP, 750 mg/5 mL by Camber Pharmaceuticals: Recall - Due to potential Bacillus cereus contamination in the product #IDTwitter fda.gov/safety/recalls-marke…
Peter Simos retweeted
🔥🔥 Now launched! Online summaries of the Australasian consensus guidelines for the use of antifungal agents in haem/onc. New: Antifungal stewardship, AND a chapter dedicated to supporting HCWs managing patients at risk for invasive fungal infections! Links to the full text are also available. #IMJ
onlinelibrary.wiley.com/jour… @NCICancer
Peter Simos retweeted
💥Just Out
ACTT-4 Trial👉First Double Placebo-Controlled Double-Blind Randomized-Stratified Head-to-Head
#DEXAMETHASONE vs #BARICITINIB for hospitalized pts w/#COVID19 Low/High-Flow/NIV
Relevant👉Patient Care/Public Health/Guidelines
Our results
👇
bit.ly/3Gac9w7
🧵1/4
Peter Simos retweeted
How close are we to the approval of the first oral #Carbapenem?
Dear antibiotic stewards,
Excited or terrified?
PDUFA JUN 27, stay tuned! #IDTwitter #MedEd #TwitteRx #MedTwitter
🔥ADAPT-PO RCT🔥 @NEJM
Oral Tebipenem Pivoxil(oral carbapenem) Hydrobromide Vs Ertapenem in Complicated Urinary Tract Infection #IDTwitter #MedEd #TwitteRx
nejm.org/doi/full/10.1056/NE…
Peter Simos retweeted
Unfortunately Sotrovimab at current dosing is not effective for ba2 as per the fda. Will be looking at this for now - however our supplies of paxlovid are good, and there is still a need for these drugs. If you are at risk please get tested
fda.gov/drugs/drug-safety-an…
Peter Simos retweeted
Possibly unpopular/uncommon opinion in med ed:
The saying goes that most diagnoses are made by H+P.
However, is this true in the year 2021?
How many of us would want to be treated by physicians only relying on H+P?
1/
Peter Simos retweeted
At @ABsteward's request, TB is pulled out into its own brand new table, including adding seminal short course, historical TB studies. So now there are 3 Shorter Is Better Tables. The original. TB Is Complex. And Exceptions. If you know of other TB RCTs, let me know!
Peter Simos retweeted
Zero covid is an illusion, anywhere in the world. It's worked in places like Australia and NZ for now,but it's not sustainable. Those countries cannot stay isolated forever.
Covid will never go away. We just have to manage it as best as possible by vaccination.
#VaccinesWork
Peter Simos retweeted
🆕🔥🔥🔥Clinical Practice Guideline @IDSAInfo @SHEA_Epi 2021 Focused Update Guidelines on Management of CDI in Adults
Major update💥:for patients with an initial CDI episode, guidelines suggest using fidaxomicin rather than a standard course of vancomycin academic.oup.com/cid/advance…
Peter Simos retweeted
I don't know who's interested in this study, but it's really an interesting concept
AWED RCT @NEJM
Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue #IDTwitter
nejm.org/doi/full/10.1056/NE…
Peter Simos retweeted
🔥Very interesting🔥
NEW #JACnews @BSACandJAC Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis #IDTwitter academic.oup.com/jac/advance…
Peter Simos retweeted
🤓📄🔬🧫
In this article Dr. Alexander talks about things to know about #ESBL
📲 idstewardship.com/5-importan…
#Badbugsneeddrugs #IDtwitter #TwitteRx #GotEnzymes?
Peter Simos retweeted
Just in! @IDSAInfo treatment guidelines for infections caused by MDR GNRs, co-authored by @SIDPharm member @OncIDPharmd! #IDTwitter
Check out the full guidelines here: idsociety.org/practice-guide…
Peter Simos retweeted
Tweetorial on peritonitis & its microbiology. 👏
Thank you, @BIDMC_IDFellows - this is a good resource!
2/
Today’s #tweetorial = PERITONITIS, which can include several different types:
Primary
Secondary
Tertiary
PD-associated
We’ll focus on SBP and PD-associated peritonitis mostly today!
